Case Definition and Phenotype Standardization in Drug‐Induced Liver Injury
By G. Aithal, P. Watkins, R. Andrade, D. Larrey, M. Molokhia, H. Takikawa, C. Hunt, R. Wilke, M. Avigan, N. Kaplowitz and 2 more. Clinical pharmacology and therapy, 2011
983 citations recorded by the source corpus.
Subfields: Epidemiology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/917529a2efd917b5891e65c8811f13d28140f812
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Andrade
- G. Aithal
- E. Bjornsson
- N. Kaplowitz
- G. Kullak-Ublick
- D. Larrey
- T. Karlsen
Citations in the corpus
- EASL Clinical Practice Guidelines: Drug-induced liver injury. (2019, background): “recovery after discontinuation of the offending drug is an important criterion in the causality assessment.(160,310) There is usually a complete or near complete resolution of DILI within”